- All bleeds
Any bleeding episode whether treated or untreated
Activated prothrombin complex concentrate (aPCC) is a scientific term for the bypassing therapy FEIBA®.
- Bypassing agent
A type of treatment developed for people with inhibitors; bypassing treatments go around (or bypass) the factors that are blocked by the inhibitor to help the body form a normal clot.
- Factor replacement therapy
A treatment that replaces the low or missing factor in people with hemophilia so that blood will clot if you have an injury.
- Intravenous Injection
A method to deliver medicine into the body that involves inserting a needle directly into the vein.
The movement of a drug into, through, and out of the body.
The regular use of a medicine to prevent something from occurring. In hemophilia, prophylaxis is intended to prevent or reduce bleeding.
A method to deliver medicine into the body that involves inserting a needle into the fatty tissue just beneath the skin.
- Therapeutic antibody
Therapeutic antibodies, often referred to as monoclonal antibodies, are designed to have the same ability as natural antibodies to bind to specific molecules. They are laboratory-produced molecules that are designed to recognize and attach to specific proteins to help treat a disease.
- Treated bleed
A bleed that requires treatment as determined by the individual or their healthcare provider.